Nutrition matters for GLP-1 drug users
We noticed it right away in 2005 when the first GLP-1 medication for people with diabetes hit the…
Ozempic Weight Loss: From willpower to prescriptions: How Ozempic is rewriting the weight-loss story
There is a moment, somewhere between a celebrity rumour and a viral before-and-after, when a drug stops being…
Keeping rebound weight off after stopping GLP-1 drugs
For many, GLP-1 (glucagon-like peptide-1) drugs like tirzepatide and semaglutide offered an ideal solution to diabetes and weight…
How GLP-1s are more than just weight-loss wonders – but not without risk
Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what…
GLP-1 plus therapy can reduce heavy drinking
May 12, 2026 At a Glance People with alcohol use disorder and obesity drank less when treated with…
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
Drugs from the GLP-1 receptor agonist class, widely used for diabetes and weight loss, are now under scrutiny…
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
Drugs from the GLP-1 receptor agonist class, widely used for diabetes and weight loss, are now under scrutiny…
New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
Treatment for diabetes and obesity is rapidly evolving, with multi-targeted approaches taking shape. Medications like semaglutide, a glucagon-like…
Should you take GLP-1 drugs for longevity?
This is, indeed, part of a wider trend of mutual support at the fringes of pharmacology, with similar…
Weight loss jab users warned they could be ‘worse off than before’
Wegovy and Mounjaro are approved by the NHS for weight loss use (Image: OMaltseva via Getty Images) People…
Weight returns four times faster after stopping weight-loss drugs
When people stop taking the new generation of weight-loss drugs, they pile back the kilos four times faster…
Are Sexual Side Effects Emerging With GLP-1 Agonists?
Few new drugs have sparked as much interest and as many questions as GLP-1 agonists. Originally developed to…